Entities / Company
Inovio Pharmaceuticals.
American biotechnology company
- Reports this week
- 2
- Active events
- 1
- Connections
- 35
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
Inovio Pharmaceuticals filed a registration statement with the Securities and Exchange Commission on July 3, 2025, with Piper Sandler Companies serving as the sole book-running manager.Speculative2 reports
-
Inovio Pharmaceuticals is scheduled to present at the Orphan Drug Summit in Boston on July 8, 2025.Speculative1 report
-
FDA completed mid-cycle review of INO-3107, and Inovio Pharmaceuticals announced the appointment of EY as its independent registered public accounting firm.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Inovio Pharmaceuticals this week
News at the entities that move Inovio Pharmaceuticals most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Inovio Pharmaceuticals
-
Securities and Exchange Commission StructuralBlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Moves Inovio Pharmaceuticals
-
Jefferies Financial Group Mentioned togetherApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Inovio Pharmaceuticals
-
Ernst & Young LLP StructuralD-BOX, headquartered in Montreal, has offices in Los Angeles and appointed Ernst & Young LLP as its independent auditor.Moves Inovio Pharmaceuticals
-
MarketBeat Mentioned togetherMarketBeat aggregates data on IDT Corporation stock performance.Moves Inovio Pharmaceuticals
-
Benzinga Mentioned togetherBenzinga reported on the recent stock price activity of SpaceX.Moves Inovio Pharmaceuticals
Connections
The 6 strongest of 35, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
Inovio Pharmaceuticals relies on the FDA for regulatory approval and designation of its pharmaceutical products.
-
Securities and Exchange Commission Structural
Inovio Pharmaceuticals is formally regulated by the Securities and Exchange Commission.
-
Ernst & Young LLP Structural
Shareholders approved Ernst & Young LLP to serve as the independent registered public accounting firm for Inovio Pharmaceuticals.
-
MarketBeat Mentioned together
MarketBeat tracks Inovio Pharmaceuticals as part of general financial blog coverage.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group provides market coverage and rating analysis for Inovio Pharmaceuticals.
-
Benzinga Mentioned together
Benzinga functions as a financial news service that covers and reports on company developments regarding Inovio Pharmaceuticals.
History
Events by the month they beganSeptember 2026
2 eventsAugust 2026
1 eventJune 2026
3 events- Inovio Pharmaceuticals filed a registration statement with the Securities and Exchange Commission on July 3, 2025, with Piper Sandler Companies serving as the sole book-running manager.
- Inovio Pharmaceuticals is scheduled to present at the Orphan Drug Summit in Boston on July 8, 2025.
- FDA completed mid-cycle review of INO-3107, and Inovio Pharmaceuticals announced the appointment of EY as its independent registered public accounting firm.